PRCT Q1 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$45M+82.5% YoY

Gross Profit

$25M56.2% margin

Operating Income

-$28M-62.1% margin

Net Income

-$26M-58.3% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$34M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$383M

Total Liabilities

$119M

Stockholders' Equity

$264M

Cash & Equivalents

$226M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$24M	+82.5%
Gross Profit	$25M	$12M	+100.4%
Operating Income	-$28M	-$28M	+2.6%
Net Income	-$26M	-$28M	+8.9%

Geographic Segments

UNITED STATES

$40M90%

Outside the United States

$4M10%